Public health collaboration Leverage IMAXIO’s focus on leptospirosis prevention and engagement with health authorities to position complementary vaccination and diagnostics partnerships with public health agencies and occupational health programs.

SME market potential Target mid-sized biotech and life sciences firms with lean teams (11-50 employees) that may benefit from cost-effective research tools, vaccine platforms, or public health awareness campaigns aligned with IMAXIO’s leptospirosis prevention initiatives.

Funding leverage Highlight opportunities to align with IMAXIO’s growth trajectory by proposing co-development, grant-ready projects, or shared-value pilots that can utilize their $3.8M funding and low-revenue profile to accelerate product validation.

Digital outreach Capitalize on IMAXIO’s digital presence and site leptospirose-prevention.fr by offering integrated digital solutions such as vaccination awareness portals, clinician education modules, and data analytics for outbreak prevention.

Tech stack compatibility Propose scalable IT and data management integrations compatible with their tech stack (Snowplow, Open Graph, reCAPTCHA, Video.js, Weebly) for secure biosurveillance dashboards, customer education experiences, and compliant privacy tooling.